
If your clinic sells bloodwork, you have probably noticed that the lab is the easy part. The hard part is everything wrapped around it: the kits, the courier that has to show up before the samples degrade, the requisition forms, the software that turns a PDF of numbers into something a patient can read, and the pile of data-protection paperwork that has to be signed before any of it can go live.
Diagnostics as a Service is the name for buying all of that as one product instead of assembling it yourself. It has become a real category over the last few years because the clinics growing fastest in preventive and longevity medicine are the ones that stopped acting as their own systems integrator. This guide explains what the model covers, how it compares with the two alternatives, what it costs, and which questions are worth asking before you sign anything.
Diagnostics as a Service, usually shortened to DaaS, is a single contract that bundles laboratory analysis, sample collection kits, courier logistics, ordering software, patient-facing result delivery, and the compliance framework underneath all of it. You order a panel through one interface, the sample gets collected and transported, an accredited lab runs it, and structured results come back into your own system under your own brand.
The useful way to think about it is by analogy with payments. A clinic that wanted to take card payments in 2005 had to talk to an acquiring bank, a gateway, a terminal supplier, and a compliance auditor. Today one provider covers all four and the clinic thinks about payments for an afternoon rather than a quarter. Diagnostics is going through the same consolidation, and DaaS is what the consolidated version is called.
One point worth being precise about, because it comes up in every first conversation: a DaaS provider is usually not itself a laboratory. It orchestrates accredited labs. That distinction matters when you start asking about quality standards, because accreditation sits with the lab that runs the analysis, while the orchestration, the software and the logistics sit with the platform.
Nobody plans it. It happens because each piece arrives at a different moment, in response to a different problem, and each one comes with its own contract.
The lab comes first, because you need someone to run the analysis. Then a patient asks for an at-home option, so a kit and logistics provider gets added. Then your team gets tired of typing patient details twice, so the practice management software has to be connected. Then patients start asking why their results arrive as a fax-era PDF, so a patient-facing app vendor joins. Then your data protection officer points out that four vendors touching patient data means four processing agreements, and a law firm is now part of your diagnostics stack.
Five vendors is five renewal dates, five invoices to reconcile, five support queues, and one clinic team acting as the integration layer between them. When something goes wrong, and with physical samples in transit something goes wrong regularly, nobody owns the whole path. The courier blames the lab, the lab blames the paperwork, and your front desk is the one explaining it to the patient.
The flow is deliberately short. Four steps cover almost every case, whether the sample is drawn in your clinic or collected by the patient at home.
The important design choice sits in the last step. In a well-built DaaS setup the patient never learns the platform's name. They book with you, they read their results under your brand, and they book the follow-up with you. The infrastructure is meant to be invisible, in the same way nobody thinks about which acquiring bank processed their coffee.
There are three realistic ways to run diagnostics at a clinic, and the right answer depends mostly on volume and on how much of your value sits in the analysis itself.
Building your own laboratory makes sense at scale, if diagnostics is your product rather than an input to it, and if you are prepared for the capital cost, the accreditation work and the staffing. Contracting labs directly is the traditional route and keeps unit prices visible, but you own every integration, every courier relationship and every data processing agreement. DaaS trades some pricing granularity for a single contract, a single integration and a much shorter path to launch.
| Criterion | Diagnostics as a Service | Your own laboratory | Direct lab contracts |
|---|---|---|---|
| Time to first patient | About four to six weeks, including white-label setup | A year or more, including accreditation and staffing | Two to four months per lab, repeated for each one |
| Upfront cost | None beyond setup, priced per patient | High capital cost for space, analysers and staff | Low, but multiplied by the number of labs you need |
| Catalogue breadth | Routine through to genomics and multi-omics in one basket | Whatever you built, specialty work still sent out | Broad only if you sign several specialty labs |
| Number of contracts | One framework agreement and one processing agreement | One per analyser vendor, plus your own accreditation | One per lab, plus kits, courier, software and legal |
| Who owns logistics | The platform, including same-day pickup and at-home kits | You, including couriers and kit sourcing | You, negotiated separately from the analysis |
| Software and patient interface | Console, API and branded patient dashboard included | Built in-house or bought as a separate product | Not included, a separate vendor |
| Result format | Structured data plus a branded PDF | Whatever your LIS produces | Varies per lab, often PDF only |
| Compliance work | Processing agreement, EU hosting and contract clauses included | Yours end to end, including lab accreditation | One agreement per vendor, assembled by you |
| Invoicing | One monthly invoice | Payroll, consumables and service contracts | One per lab and per service provider |
| Best fit | Clinics selling broad panels without an in-house lab | High-volume operations where analysis is the product | Narrow routine testing at a single site |
One nuance that the table cannot show. With direct lab contracts the specialty modalities are usually where the model breaks down, because the lab that runs your routine chemistry rarely runs your sequencing, your proteomics and your microbiome work as well. So the clinic that started with one lab contract ends up with four, and the reconciliation problem grows with the ambition of the panel.
When a provider says they cover diagnostics end to end, these are the pieces that claim has to include. It is a useful checklist to read a proposal against.
If a proposal is missing two or three of these, it is not a DaaS offer. It is a lab contract with a nicer cover page, and the gaps will land back on your team.
The model earns its place fastest where diagnostics is a visible part of what the patient buys, and where the panel is broader than a standard chemistry order.
The model fits less well if your volume is small and entirely routine, in which case a single local lab contract is simpler, or if the analysis itself is your intellectual property, in which case you probably want your own lab.
German and EU rules put real constraints on this model, and a provider that cannot name them without checking is a provider you should keep asking questions of. Six things matter.
These are the questions that separate a provider you can build a programme on from one you will be working around within six months. Ask them in the first call.
The honest answer is that it depends on your basket and your volume, but the shape of the comparison is consistent. A clinic buying a broad multi-omics workup from specialist labs separately pays a chemistry lab for the routine markers, a hormone specialist for the endocrine panel, a nutrient and immunology lab for vitamins and autoantibodies, and a genomics or specialty lab for sequencing and microbiome work. Add those four together and a single ambitious patient workup lands in the region of 700 EUR.
Consolidated under one platform, the same modalities come in at roughly half that, in the region of 340 EUR per patient for a broad workup, because the panel is bought as one basket rather than four, the logistics are a flat fee per draw day, and only the white-label module is priced as an add-on. The saving is not magic. It is what happens when four separate sales relationships and four separate courier runs collapse into one.
Both figures are indicative per-patient ranges based on typical clinic baskets and standard 2025 to 2026 reference pricing across European specialty labs. Real pricing scales with volume and panel mix, so treat them as the shape of the answer rather than the answer.
Aniva is a Diagnostics-as-a-Service platform for European clinics. More than 2,500 parameters are available through one contract, from routine bloodwork and hormone panels through to whole-genome sequencing, transcriptomics, proteomics and microbiome analysis, and clinics reach them either through an admin console or through one API.
The laboratory work for routine and specialty bloodwork runs at ZOTZ|KLIMAS, which holds the RiliBÄK and ISO 15189 coverage, with a curated set of specialty partners behind the genomics and multi-omics modalities. Core panels return within 24 hours of pickup. Data processing is EU-native and hosted in Germany, and the processing agreement is part of the standard onboarding pack rather than a negotiation. The typical path from a signed framework agreement to the first patient draw, including white-label setup, is about four weeks.
What that looks like in production: Kalia Lab runs the longevity bloodwork for its clinics in Berlin, Hamburg and Duesseldorf on Aniva. Patients buy a Kalia package, read their results in Kalia's own app, and book their follow-up with Kalia. Three locations went live from day one, the integration took four weeks, and a patient who walks in at ten to four still gets a same-day courier pickup.
The Aniva for Clinics overview lives on Aniva for practitioners, and the platform itself is described on the Diagnostics as a Service page. If you are building the software side yourself, the companion article covers the same model from a product and engineering point of view, including the API surface and what a diagnostics integration actually takes: Diagnostics as a Service for digital health products.
Diagnostics as a Service is not a new kind of laboratory. It is a decision about where the integration work lives. Run it yourself and you keep maximum control over unit pricing while your clinic team spends its week chasing couriers and reconciling invoices. Buy it as a service and you trade some of that granularity for one contract, one integration, one invoice, and a patient experience that stays inside your brand.
For most clinics selling preventive or longevity bloodwork today, the second trade is the better one, because the thing patients pay for is the panel and the conversation that follows it, not the logistics underneath. The questions above are what turn that general case into a decision you can defend to your own team.
Diagnostics as a Service is a single contract that covers laboratory analysis, collection kits, courier logistics, ordering software, patient-facing result delivery and the compliance framework around them. The clinic orders panels through one interface and receives structured results under its own brand, instead of managing a lab, a logistics provider, a software vendor, an app vendor and a law firm separately.
Usually not. Most DaaS providers orchestrate accredited laboratories rather than owning one. Accreditation such as RiliBÄK and ISO 15189 sits with the lab that runs the analysis, while the software, the logistics, the catalogue and the compliance framework sit with the platform. Ask any provider to name the labs behind their catalogue.
In a properly white-labelled setup, your clinic. Your logo and colours appear on the patient dashboard, your branding on the result PDF, and your sub-domain if you want one. Ask each provider where their own name reappears in the patient flow, because the depth of white-labelling varies a lot between offers.
Four to six weeks is a realistic range for a clinic that already draws blood, covering panel selection, contract and data paperwork, white-label setup and a first pilot. An API integration can run in parallel, and it is worth confirming whether the timeline you are quoted includes the compliance documents or only the technical work.
Dashboards that display laboratory results, show reference ranges and add context are normally designed to be non-qualifying under MDR, IVDR and MPDG, with diagnostic interpretation remaining with the treating clinician. Where a specific panel or feature sits closer to that boundary, the assumptions belong in the contract, documented rather than assumed.
Ask three concrete questions. Where is the data physically hosted, which sub-processors touch the patient data path, and is any of them outside the EEA. A provider working with German clinics should be able to answer all three immediately and hand you a processing agreement with the sub-processor list already enumerated.
Yes, and most providers support several collection methods in the same catalogue. A venous draw in the clinic, a capillary kit for finger-prick collection, a mailed at-home kit with prepaid return, plus saliva, stool and urine for the panels that require them. The relevant question is whether all of them share one ordering flow and one result format.
It varies. Some providers set a floor, others price purely on volume and panel mix. Either way, the number you want out of a first call is the per-patient cost of your actual basket at your actual volume, including logistics and any white-label module, rather than a list price for a panel you do not sell.
Aniva runs the lab network, the kits, the logistics, the software and the compliance paperwork behind more than 2,500 parameters, under your clinic's brand. See Aniva for practitioners for the clinic view, Diagnostics as a Service for the platform, and bring your typical patient basket to the first call so the quote is a real number rather than a list price.
This article is general information for clinic operators about how diagnostics services are structured and procured. It is not medical, legal or tax advice, and it does not describe any diagnosis or treatment. Laboratory accreditation and reference ranges are held by the analysing laboratory, and any interpretation of a patient result remains with the treating clinician. Prices are indicative and not an offer.